Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea

被引:101
作者
Ryoo, NH
Kim, EC
Hong, SG
Park, YJ
Lee, K
Bae, IK
Song, EH
Jeong, SH
机构
[1] Keimyung Univ, Coll Med, Dept Lab Med, Taegu, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul, South Korea
[3] Pochon CHA Univ, Coll Med, Sungnam, South Korea
[4] Catholic Univ, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea
[7] Kosin Univ, Coll Med, Dept Lab Med, Pusan, South Korea
关键词
ESBLs; resistance; prevalence;
D O I
10.1093/jac/dki324
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To assess the prevalence and genotypes of Ambler class A extended-spectrum beta-lactamases (ESBLs) in Korea. Methods: Clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 12 Korean hospitals during February-July 2003 were evaluated. Antimicrobial susceptibilities were determined by disc diffusion and agar dilution methods, and the putative ESBL-producing strains were tested by the double-disc synergy method. Detection of genes encoding class A beta-lactamases was performed by PCR amplification, and the PCR products were subjected to direct sequencing. Results: The double-disc synergy test showed positive results in 9.3% (23/246) of E. coli and 23.0% (55/239) of K. pneumoniae isolates. The most prevalent types of Ambler class A ESBLs in E. coli isolates were CTX-M-15 (n = 4) and CTX-M-3 (n = 3), and those in K. pneumoniae isolates were SHV-12 (n = 30) and CTX-M-3 (n = 13). Two isolates produced both SHV-12 and GES-3, simultaneously. Conclusions: CTX-M-type and/or SHV-12 ESBL-producing E. coli and K. pneumoniae isolates are spreading, and a GES-type ESBL has emerged in Korea.
引用
收藏
页码:698 / 702
页数:5
相关论文
共 10 条
[1]  
Bae I.K., 2004, KOREAN J CLIN MICROB, V7, P48
[2]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[3]   Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Eschetichia coli from a Korean nationwide survey [J].
Jeong, SH ;
Bae, IK ;
Lee, JH ;
Sohn, SG ;
Kang, GH ;
Jeon, GJ ;
Kim, YH ;
Jeong, BC ;
Lee, SH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) :2902-2906
[4]   Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases:: Prevalence of SHV-12 and SHV-2a in Korea [J].
Kim, J ;
Kwon, Y ;
Pai, H ;
Kim, JW ;
Cho, DT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (05) :1446-1449
[5]  
*NCCLS, 2003, M100S14 NCCLS
[6]  
NCCLS, 2003, M7A6 NCCLS
[7]   Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae:: Prevalence of TEM-52 in Korea [J].
Pai, H ;
Lyu, S ;
Lee, JH ;
Kim, J ;
Kwon, Y ;
Kim, JW ;
Choe, KW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1758-1763
[8]   GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem [J].
Poirel, L ;
Weldhagen, GF ;
Naas, T ;
De Champs, C ;
Dove, MG ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2598-2603
[9]   Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria [J].
Vourli, S ;
Giakkoupi, P ;
Miriagou, V ;
Tzelepi, E ;
Vatopoulos, AC ;
Tzouvelekis, LS .
FEMS MICROBIOLOGY LETTERS, 2004, 234 (02) :209-213
[10]   Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A β-lactamase, GES-3, in a neonatal intensive care unit in Japan [J].
Wachino, J ;
Doi, Y ;
Yamane, K ;
Shibata, N ;
Yagi, T ;
Kubota, T ;
Ito, H ;
Arakawa, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :1960-1967